Literature DB >> 3718907

Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes.

L S Mengher, K S Pandher, A J Bron, C C Davey.   

Abstract

We evaluated the effect of 0.1% sodium hyaluronate (unpreserved) in 10 patients with dry eyes. The precorneal tear film break-up time was assessed by the non-invasive technique, and the severity of symptoms was recorded before and after treatment on a 0 to +3 scale. It was found that the tear film stability was significantly increased (p less than 0.05) in eyes treated with sodium hyaluronate. The symptoms of grittiness and burning were also significantly alleviated in the treated eyes.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3718907      PMCID： PMC1041038          DOI： 10.1136/bjo.70.6.442

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  13 in total

1.  Extraocular fluid dynamics: how best to apply topical ocular medication.

Authors:  F T Fraunfelder
Journal:  Trans Am Ophthalmol Soc       Date:  1976

2.  Management of the dry eye in Sjogren's syndrome.

Authors:  J Williamson; W M Doig; J V Forrester; M H Tham; T Wilson; K Whaley; W C Dick
Journal:  Br J Ophthalmol       Date:  1974-09       Impact factor: 4.638

3.  Artificial tear solutions.

Authors:  M A Lemp
Journal:  Int Ophthalmol Clin       Date:  1973

4.  Recent advances in ocular surface chemistry.

Authors:  M A Lemp; F J Holly
Journal:  Am J Optom Arch Am Acad Optom       Date:  1970-09

5.  Effect of fluorescein instillation on the pre-corneal tear film stability.

Authors:  L S Mengher; A J Bron; S R Tonge; D J Gilbert
Journal:  Curr Eye Res       Date:  1985-01       Impact factor: 2.424

6.  Cellulose acetate impressions of the ocular surface. Dry eye states.

Authors:  J D Nelson; V R Havener; J D Cameron
Journal:  Arch Ophthalmol       Date:  1983-12

7.  Letter: Fine cotton thread method of lacrimation.

Authors:  K Kurihashi
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

8.  The use of topical Healon tears in the management of refractory dry-eye syndrome.

Authors:  V P DeLuise; W S Peterson
Journal:  Ann Ophthalmol       Date:  1984-09

9.  Kinetics of lacrimal secretions in normal human subject.

Authors:  F K Holly; S J LauKaitis; E D Esquivel
Journal:  Curr Eye Res       Date:  1984-07       Impact factor: 2.424

Review 10.  Tear physiology and dry eyes.

Authors:  F J Holly; M A Lemp
Journal:  Surv Ophthalmol       Date:  1977 Sep-Oct       Impact factor: 6.048
View more
  17 in total

1.  Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.

Authors:  P Prabhasawat; N Tesavibul; N Kasetsuwan
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

2.  Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.

Authors:  Françoise Brignole; Pierre-Jean Pisella; Bénédicte Dupas; Vincent Baeyens; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

3.  Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.

Authors:  Pasquale Aragona; Vincenzo Papa; Antonio Micali; Marcello Santocono; Giovanni Milazzo
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

4.  Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome.

Authors:  P I Condon; C G McEwen; M Wright; G Mackintosh; R J Prescott; C McDonald
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

5.  Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye.

Authors:  N Yokoi; A Komuro; K Nishida; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

6.  Characterization of glycidyl methacrylate - crosslinked hyaluronan hydrogel scaffolds incorporating elastogenic hyaluronan oligomers.

Authors:  S Ibrahim; C R Kothapalli; Q K Kang; A Ramamurthi
Journal:  Acta Biomater       Date:  2010-08-13       Impact factor: 8.947

7.  Nanostructured hybrid hydrogels prepared by a combination of atom transfer radical polymerization and free radical polymerization.

Authors:  Sidi A Bencherif; Daniel J Siegwart; Abiraman Srinivasan; Ferenc Horkay; Jeffrey O Hollinger; Newell R Washburn; Krzysztof Matyjaszewski
Journal:  Biomaterials       Date:  2009-07-09       Impact factor: 12.479

8.  Sodium hyaluronate eyedrops in the treatment of dry eyes.

Authors:  S Shimmura; M Ono; K Shinozaki; I Toda; E Takamura; Y Mashima; K Tsubota
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

Review 9.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

10.  Conservative treatment for late-onset bleb leaks after trabeculectomy with mitomycin C in patients with ocular surface disease.

Authors:  Hideto Sagara; Tomohiro Iida; Kimimori Saito; Hiroki Noji; Masashi Ogasawara; Hiroshi Oyamada
Journal:  Clin Ophthalmol       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.